ProfileGDS5678 / 1459097_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 10% 9% 10% 9% 9% 10% 13% 9% 9% 10% 9% 9% 9% 9% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.263210
GSM967853U87-EV human glioblastoma xenograft - Control 22.225189
GSM967854U87-EV human glioblastoma xenograft - Control 32.2366710
GSM967855U87-EV human glioblastoma xenograft - Control 42.179179
GSM967856U87-EV human glioblastoma xenograft - Control 52.176569
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.3100310
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.3585513
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.21249
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.189839
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.2256110
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.22039
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.202689
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.227489
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.226729